Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humana Biosciences is an active preclinical contract research organization specializing in tailored translational pharmacology studies. The company provides custom-designed in vitro and in vivo experimental models to improve the predictive value of preclinical drug development. Its core areas include gastroenterology, urology, respiratory diseases, dermatology, and nephrology. The company collaborates with nutraceutical firms and those working with medicinal plant extracts. Internal R&D focuses on botulinum toxin potency testing, advanced cell culture systems for respiratory disease modeling, animal models for asthma/COPD research, and comparative smooth muscle pharmacology using pig/human tissues. Founded by Dr. Stefano Palea—a recognized expert in urological pharmacology—the team has deep experience across pharma/biotech/academia with over 750 peer-reviewed publications collectively.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humana Biosciences.